R. Santana

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

Y. Perera, G. Guillén, Ariadna Garcia, 2020, medRxiv.